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ABSTRACT
We have previously shown that the replication of avian reovirus (ARV) in chicken cells is much more resistant to interferon
(IFN) than the replication of vesicular stomatitis virus (VSV) or vaccinia virus (VV). In this study, we have investigated the role
that the double-stranded RNA (dsRNA)-activated protein kinase (PKR) plays in the sensitivity of these three viruses toward the
antiviral action of chicken interferon. Our data suggest that while interferon priming of avian cells blocks vaccinia virus replica-
tion by promoting PKR activation, the replication of vesicular stomatitis virus appears to be blocked at a pretranslational step.
Our data further suggest that the replication of avian reovirus in chicken cells is quite resistant to interferon priming because
this virus uses strategies to downregulate PKR activation and also because translation of avian reovirus mRNAs is more resistant
to phosphorylation of the alpha subunit of initiation factor eIF2 than translation of their cellular counterparts. Our results fur-
ther reveal that the avian reovirus protein sigmaA is able to prevent PKR activation and that this function is dependent on its
double-stranded RNA-binding activity. Finally, this study demonstrates that vaccinia virus and avian reovirus, but not vesicular
stomatitis virus, express/induce factors that counteract the ability of dithiothreitol to promote eIF2 phosphorylation. Our data
demonstrate that each of the three different viruses used in this study elicits distinct responses to interferon and to dithiothre-
itol-induced eIF2 phosphorylation when infecting avian cells.
IMPORTANCE
Type I interferons constitute the first barrier of defense against viral infections, and one of the best characterized antiviral strate-
gies is mediated by the double-stranded RNA-activated protein kinase R (PKR). The results of this study revealed that IFN prim-
ing of avian cells has little effect on avian reovirus (ARV) replication but drastically diminishes the replication of vaccinia virus
(VV) and vesicular stomatitis virus (VSV) by PKR-dependent and -independent mechanisms, respectively. Our data also demon-
strate that the dsRNA-binding ability of ARV protein sigmaA plays a key role in the resistance of ARV toward IFN by preventing
PKR activation. Our findings will contribute to improve the current understanding of the interaction of viruses with the host’s
innate immune system. Finally, it would be of interest to uncover the mechanisms that allow avian reovirus transcripts to be effi-
ciently translated under conditions (moderate eIF2 phosphorylation) that block the synthesis of cellular proteins.
Interferons (IFNs) comprise a family of multifunctional cyto-kines that were originally discovered by their strong antiviral
activity and which are now recognized as the first barrier that
viruses must overcome to establish a productive infection. Of the
three IFN types, type I interferon (IFN-/) displays the highest
antiviral activity, and its expression is induced in many cell types
by viral infection or following contact with double-stranded RNA
(dsRNA) (1, 2). Type I IFNs are secreted out of the cell where
they interact with the ubiquitously expressed type I IFN recep-
tor (IFNAR) complex. This interaction triggers the activation of a
signal transduction pathway that leads to increased expression of
IFN-stimulated genes (ISGs), thus creating an antiviral state. Sub-
sequent viral infection of IFN-primed cells induces the activation
of some of the ISG-encoded proteins, and the antiviral activity of
these proteins prevents further dissemination of the virus (3–6).
Two of the many ISG-encoded proteins have been shown to play
an important role in inhibiting viral protein synthesis within in-
fected cells; they are the 2=,5=-oligoadenylate synthetase (OAS)
and the double-stranded RNA (dsRNA)-activated protein kinase
(PKR). Increased expression of these enzymes is induced by IFN,
but they remain latent until after activation by dsRNA (7, 8). Ac-
tivated OAS catalyzes the synthesis of short oligonucleotides of the
general structure ppp(A2=p5=)nA. These oligonucleotides bind to
and stimulate a latent endoribonuclease, designated RNase L, to
degrade both cellular and viral RNAs, thus preventing intracellu-
lar protein synthesis (9, 10). On the other hand, the interaction of
PKR with dsRNA leads to dimerization and kinase activation,
which then catalyzes serine/threonine phosphorylation of differ-
ent substrates, including the alpha subunit of the eukaryotic trans-
lation initiation factor 2 (eIF2) (11, 12). Phosphorylation of
eIF2 can also be carried by three other well-characterized serine-
threonine kinases, PERK (PKR-like endoplasmic reticulum ki-
nase), GCN2 (general control nonderepressible-2), and HRI
(heme-regulator inhibitor) (13, 14).
The initiation factor eIF2 plays a key role in the initiation of
translation. GTP-bound eIF2 recruits Met-tRNAi to the 40S ribo-
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somal subunit, thus facilitating recognition of the initiator codon
by the scanning 43S complex. Binding of the 60S ribosomal sub-
unit to the preinitiation complex promotes hydrolysis of GTP,
releasing eIF2-GDP from the ribosome. In order to start another
round of translation initiation, replacement of GDP by GTP on
eIF2 is catalyzed by the guanosine nucleotide exchange factor
eIF2B. However, when eIF2 becomes phosphorylated on Ser-51,
it binds very tightly to eIF2B, thus blocking the capacity of this
factor to exchange guanosine nucleotides. As a consequence, the
intracellular levels of active eIF2-GTP drastically fall, and protein
synthesis initiation is inhibited. Since the intracellular levels of
eIF2B are usually lower than those of eIF2, phosphorylation of a
fraction of the eIF2 molecules present in the cell is usually
enough to disallow the catalytic function of eIF2B. This leads to
inhibition of global translation initiation while facilitating the
preferential translation of specific stress-related mRNAs, includ-
ing the mRNA encoding activating transcription factor 4 (ATF4)
(15–17).
In order to sustain a productive infection, viruses have evolved
a variety of antagonistic strategies to undermine virtually all parts
of the IFN system, including inhibition of IFN induction and/or
signaling or blocking the synthesis, activation, and/or activity of
ISG-encoded proteins (18, 19). In addition, many viruses express
products that bind and sequester dsRNA, thus limiting IFN induc-
tion and the activation of dsRNA-dependent antiviral enzymes
(20, 21). The anti-IFN strategies displayed by a virus not only are
virus specific but also vary depending on the type of virus-infected
cell (18, 22).
Previous studies from different laboratories, including ours,
have shown that replication of avian reovirus (ARV) in cultured
avian cells is highly refractory to the antiviral action of chicken
IFN (chIFN); thus, the replication of ARV is much more resistant
to chIFN than the replication of vaccinia virus (VV), vesicular
stomatitis virus (VSV), or Semliki Forest virus (23–25). Subse-
quent results from our laboratory further suggested that ARV core
protein sigmaA, which binds dsRNA irreversibly, plays a key role
in protecting ARV against the antiviral effect of IFN by preventing
PKR activation (24, 26, 27) although this suggestion was based on
indirect evidence. In this study, we have investigated the molecu-
lar mechanisms that control the sensitivity of ARV, VV, and VSV
toward the antiviral activity of a recombinant chicken IFN- and
toward dithiothreitol (DTT)-induced eIF2 phosphorylation in
avian cells.
MATERIALS AND METHODS
Cells, viruses, and plasmids. Chicken embryo fibroblast (CEF) primary
cultures were prepared from 9- to 10-day-old chicken embryos (provided
by Laboratorios MSD España, Salamanca, Spain) and grown in monolay-
ers in medium 199 supplemented with 10% tryptose phosphate broth and
5% calf serum. Avian DF1 cells and hamster BHK-21 cells (both pur-
chased from ATCC, Manassas, VA) were maintained in monolayers in
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen). Vaccinia vi-
rus Western Reserve (VV), the recombinant vaccinia viruses VV-Luc (28)
and VV-S2 (26), and vesicular stomatitis virus Indiana serotype (VSV)
were grown on BHK-21 cells, while avian reovirus S1133 strain (ARV) was
grown on CEF cells. The construction of plasmids expressing ARV pro-
teins sigmaA and sigmaA R155A has been previously described (26, 29).
Antibodies and reagents. Generation of rabbit polyclonal antibodies
against ARV proteins sigmaA and NS has been previously described (26,
30). Rabbit polyclonal anti-chicken PKR (chPKR) antibody was produced
by BioSynthesis, using as hapten a synthetic peptide comprising amino
acid residues 527 to 550 of chicken PKR. Rabbit polyclonal antibody
against E3 VV proteins was a kind gift from Mariano Esteban (Centro
Nacional de Biotecnología, Madrid, Spain). Rabbit polyclonal antibodies
against human eIF2 (FL-315) and actin (I-19) were from Santa Cruz
Biotechnology. Rabbit monoclonal antibody against a synthetic phospho-
peptide corresponding to residues surrounding Ser-51 of human eIF2
(9721) was purchased from Cell Signaling Technology, and mouse anti-
dsRNA (J2) monoclonal antibody was from Scicons. The J2 antibody,
which recognizes dsRNAs of more than 40 bp but not ribosomal RNAs,
has been previously used to detect dsRNA intermediates of several viruses
(31, 32). The secondary antibodies used in Western blotting (horseradish
peroxidase [HRP]-conjugated goat anti-rabbit IgG) and immunofluores-
cence (Alexa Fluor 488 goat anti-rabbit IgG and Alexa Fluor 594 goat
anti-mouse IgG) were purchased from Sigma and Invitrogen, respec-
tively.
Dithiothreitol (DTT), the PKR inhibitor imidazole/oxindole (C16),
and the synthetic dsRNA poly(I·C) were purchased from Sigma, while
alkaline phosphatase was from Promega. Recombinant chicken IFN-
was obtained from AbD Serotec.
Viral infections, metabolic radiolabeling, and Western blotting.
Semiconfluent monolayers of avian cells, which were untreated or had
been treated with a recombinant chicken IFN- for 24 h, were incubated
with the virus indicated in the figure legends for 1 h at 37°C. Then, unad-
sorbed virus was removed (this moment was considered time zero of
infection), and cells were overlaid with medium 199 containing 2.5% fetal
calf serum and incubated at 37°C for the times indicated in the text. For
metabolic radiolabeling, the cell culture medium was replaced by methi-
onine/cysteine-free medium containing 100 Ci/ml of [35S]methionine-
cysteine (Hartmann Analytic). The cells were incubated in this medium
for 1 h, then washed twice with phosphate-buffered saline (PBS), lysed in
radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl [pH
8.0], 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, and
0.1% SDS), and finally boiled in Laemmli sample buffer. The samples
were subjected to 10% SDS-PAGE and autoradiography. For densitomet-
ric analysis, the films were analyzed with a Gel Doc XR system and the
Quantity One 1-D Analysis software (Bio-Rad).
For Western blotting, the cells were washed twice with PBS and har-
vested in buffer I (20 mM Tris-HCl [pH 7.5], 50 mM KCl, 400 mM NaCl,
1 mM EDTA, 1% Triton X-100, 5 mM 2-mercaptoethanol, 20% glycerol)
supplemented with phosphatase and protease inhibitors. Samples were
then boiled for 5 min in Laemmli sample buffer and resolved by SDS-
PAGE, and the proteins were transferred to polyvinylidene difluoride
(PVDF) membranes (Immobilon-P; Millipore). To improve the separa-
tion of the chPKR isoforms, the gels were allowed to run until the
prestained 55-kDa marker band reached the bottom of the gel. Mem-
branes were blocked for 1 h with PBS containing 0.05% Tween 20 and 4%
nonfat dry milk and incubated for 2 h with primary antibodies diluted in
blocking solution. After several washes, the membranes were incubated
for 45 min with HRP-conjugated goat anti-rabbit IgG and visualized by
chemiluminescence (Immobilon Western Chemiluminescent HRP sub-
strate; Millipore).
Transfection and alkaline phosphatase treatment. Plasmid transfec-
tion was done using Lipofectamine 2000 according to the manufacturer’s
instructions. For dsRNA transfection, 10 g of poly(I·C) was incubated
with 10 l of Lipofectamine 2000 for 15 min, and the sample was then
added to the cell monolayers at a poly(I·C) concentration of 10 g/ml. For
alkaline phosphatase treatment, cells were lysed in buffer I lacking phos-
phatase inhibitors, and the resulting extracts were diluted with alkaline
phosphatase buffer. The samples were then incubated with 167 U/ml of
alkaline phosphatase for 1 h at 37°C and finally boiled in Laemmli sample
buffer.
Indirect immunofluorescence. Cells were grown on coverslips,
washed twice with PBS, and fixed for 10 min with 4% paraformaldehyde
in PBS. Fixed cells were washed with PBS, permeabilized with 0.5% Triton
X-100 in PBS for 3 min, and then blocked with 2% bovine serum albumin
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in PBS for 30 min. The cells were subsequently incubated for 2 h with
primary antibodies diluted 1:1,000 in blocking buffer, washed three times
with PBS, and incubated for 30 min with secondary antibodies and 4=,6=-
diamidino-2-phenylindole (DAPI). After several washes with PBS, cover-
slips were mounted on glass slides. Images were obtained with an Olym-
pus DP-71 digital camera mounted on an Olympus BX51 fluorescence
microscope and processed with Adobe Photoshop.
RESULTS
PKR activity in IFN-primed virus-infected avian cells. Previous
studies have shown that the synthesis of viral proteins in VSV- and
VV-infected CEFs, but not in ARV-infected CEFs, is very sensitive
to IFN priming (23–26). Since PKR is an IFN-induced protein that
upon activation phosphorylates eIF2 and causes protein synthe-
sis inhibition (11, 12), we sought to determine the role that this
kinase plays in the sensitivity of these three viruses toward a re-
combinant chIFN- (33). To monitor the degree of PKR activa-
tion in avian cells, we wanted to compare the intracellular levels of
total versus phosphorylated PKR by Western blotting. We also
wanted to monitor intracellular PKR activity by determining the
degree of eIF2 phosphorylation in infected avian cells. Test as-
says revealed that commercial antibodies generated against hu-
man eIF2 (total eIF2) and against a human eIF2 hapten con-
taining phosphorylated Ser-51 (phosphorylated eIF2) were both
able to recognize the eIF2 expressed by chicken cells, so we used
these antibodies to monitor the degree of eIF2 phosphorylation
in avian cells. In contrast, commercial antibodies generated
against human and mouse PKR failed to recognize chPKR, and
therefore these antibodies could not be used to monitor the phos-
phorylation status of chPKR. To try to overcome this problem, we
generated rabbit antiserum against a peptide comprising residues
527 to 550 of chPKR and tested whether this antiserum could serve
to distinguish the phosphorylated (active) and nonphosphory-
lated (inactive) chPKR isoforms by Western blotting, an approach
that has been successfully used to monitor the activation of mam-
malian PKRs (34). To accomplish this, IFN-treated avian cells
were either untransfected or transfected with PKR activator
poly(I·C) and lysed 4 h later, and the resulting extracts were ana-
lyzed by immunoblotting, either before or after incubation with
alkaline phosphatase. These experiments were performed in CEF
cells, as well as in the CEF-derived avian cell line DF1. To improve
the electrophoretic separation of the phosphorylated and non-
phosphorylated PKR isoforms, the samples were allowed to run
much longer than during a routine electrophoretic analysis.
The immunoblot assay shown in Fig. 1A revealed that IFN
priming induced PKR expression in the two cell types without
promoting eIF2 phosphorylation (compare lanes 1 and 2 and
lanes 5 and 6 in panels a and b). This result suggests that the PKR
expressed by IFN-treated uninfected chicken cells is catalytically
inactive and therefore that the chPKR bands observed in lanes 2
and 6 in panel a of Fig. 1A should correspond to unphosphoryl-
ated/inactive PKR. Strikingly, the PKR expressed in IFN-treated
CEF cells, but not in DF1 cells, resolved as two bands of different
electrophoretic mobilities (Fig. 1A, lane 2 of panel a), suggesting
that the various cell types present in the primary CEF cultures
express two PKR isoforms of different lengths, a situation similar
to that reported for human PKR, where cells of different human
tissues express two PKR isoforms, one being 40 residues longer
than the other (GeneID 5610; GenBank accession number P19
525) (35, 36). Transfection of dsRNA into IFN-treated avian cells
showed different responses in the two cell types. Thus, its trans-
fection into DF1 cells significantly diminished the intensity of the
band corresponding to unphosphorylated PKR and caused a con-
comitant increase in the intensity of a slower-migrating PKR band
(Fig. 1A, compare lanes 6 and 7 in panel a), which likely represents
a hyperphosphorylated/active PKR isoform since its appearance
was accompanied by a great increase in the degree of eIF2 phos-
phorylation (Fig. 1A, compare lanes 6 and 7 in panel b). This was
confirmed by our finding that the slower-migrating PKR band
disappeared upon incubation of the cell extract with alkaline
phosphatase (Fig. 1A, compare lanes 7 and 8 in panel a). These
results validate the use of our anti-chPKR antibody for monitor-
ing PKR phosphorylation/activation in DF1 cells by immunoblot-
ting. We also observed that eIF2 resolved as two protein bands in
the dsRNA-transfected DF1 cells (Fig. 1A, panels b and c, lanes 7
and 8), which is in agreement with the reported observations that
dsRNA transfection leads to apoptosis and that effector caspases
catalyze partial cleavage of eIF2 (37, 38). Surprisingly, incuba-
tion of the cell extracts with alkaline phosphatase caused dephos-
phorylation of PKR but not of eIF2 (Fig. 1A, compare lanes 7 and
8 in panels a and b). A possible explanation for this situation is that
phosphorylated eIF2 binds so tightly to the guanosine nucleotide
exchange factor eIF2B that alkaline phosphatase access to the
phosphorylated Ser-51 of eIF2 present within the eIF2-eIF2B
complex is blocked.
The effect of dsRNA transfection on IFN-treated CEF cells was
less apparent; we observed a small decrease in the intensity of the
faster-migrating PKR band and a moderate increase both in the
intensity of an intermediate migrating PKR band and in the degree
of eIF2 phosphorylation (Fig. 1A, compare lanes 2 and 3 in pan-
els a and b) although the increase in eIF2 phosphorylation was
lower than that observed in DF1 cells (Fig. 1A, compare lanes 3
and 7 in panel b). This, and the fact that the intensity of the inter-
mediate migrating PKR band is highly reduced after alkaline
phosphatase treatment (Fig. 1A, compare lanes 3 and 4 in panel a),
suggest that the intermediate migrating PKR band might repre-
sent a hypophosphorylated/low-activity PKR isoform, which in
turn suggests either that transfected dsRNA is not a powerful ac-
tivator of CEF PKR or that the PKR expressed by CEF cells is not
able to reach full phosphorylation.
Once we demonstrated that our chPKR antiserum can be used
to monitor the activation of the avian kinase by Western blotting,
we next analyzed the effect that IFN priming exerts on both pro-
tein synthesis and PKR activation in infected avian cells. As a pos-
itive control for phosphorylated eIF2, avian cells were treated
with dithiothreitol (DTT), a reducing agent that activates the en-
doplasmic reticulum kinase PERK to induce eIF2 phosphoryla-
tion and protein synthesis inhibition in mammalian cells (39, 40).
The results shown in lanes 9 of Fig. 1B and C revealed that DTT
was able to induce similar effects in avian cells. IFN priming of
uninfected avian cells induced PKR expression but not its activa-
tion since it did not promote the appearance of the lower-mobility
PKR isoform, did not inhibit cellular protein synthesis, and did
not promote eIF2 phosphorylation (Fig. 1B and C, compare
lanes 1 and 2), thus confirming that IFN induces the expression of
unphosphorylated/inactive PKR in uninfected cells. PKR activa-
tion and eIF2 phosphorylation were also not observed in IFN-
primed ARV-infected avian cells (Fig. 1B and C, compare lanes 3
and 4 in panels c and d). Curiously, while IFN priming slightly
reduced the synthesis of viral proteins in ARV-infected CEF cells,
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it slightly increased the synthesis of ARV proteins and diminished
the synthesis of cellular proteins in ARV-infected DF1 cells (Fig.
1B and C, compare lanes 3 and 4 in panels a and b), suggesting that
IFN priming slightly enhances ARV replication in DF1 cells.
IFN priming of VSV-infected cells induced PKR expression,
but most of the protein (90%) migrated in the position corre-
sponding to unphosphorylated PKR (Fig. 1B and C, compare
lanes 5 and 6 in panel c), suggesting that most PKR expressed in
these cells is catalytically inactive. This suggestion was further sup-
ported by the fact that IFN priming of VSV-infected CEF cells was
not accompanied by a significant increase of eIF2 phosphoryla-
tion (Fig. 1B, panel d, lane 6), and although a slight phosphoryla-
tion rise was observed in VSV-infected DF1 cells (Fig. 1C, panel d,
lane 6), this rise was not consistent since it was not detected in
other experiments (Fig. 2C, compare lanes 9 and 11 in panel c). On
the other hand, IFN priming of VSV-infected cells induced a dras-
tic inhibition of viral protein synthesis and a partial rescue of
cellular protein synthesis (Fig. 1B and C, lanes 5 and 6 in panels a,
and 2B, lanes 9 and 11 in panel a). Finally, IFN priming of VV-
infected cells promoted PKR expression and full kinase activation,
as revealed by the electrophoretic mobility shift of PKR toward the
lower-mobility isoform and by enhanced levels of phosphorylated
eIF2. These effects were accompanied by a drastic inhibition of
viral and cellular protein synthesis (Fig. 1B and C, compare lanes
7 and 8 in panels a, and 2B, compare lanes 5 and 7 in panel a).
These results suggest that PKR plays a key role in the sensitivity of
VV toward the antiviral effect of IFN in avian cells.
To further assess the role that chPKR plays in the sensitivity of
VSV and VV toward IFN, we next examined the effect of a specific
PKR inhibitor, the oxindole/imidazole derivative C16. This low-
FIG 1 PKR activation in virus-infected cells. (A) Monolayers of CEF (lanes 1 to 4) or DF1 (lanes 5 to 8) cells were left untreated (lanes 1 and 5) or incubated (lanes
2 to 4 and 6 to 8) with 1,000 U/ml of chIFN for 24 h. One set of the cells was then mock transfected (lanes 1, 2, 5, and 6), and the other set was transfected with
10 g/ml of poly(I·C) (lanes 3, 4, 7, and 8). The cells were lysed 4 h later, and the resulting cell extracts were processed for Western blotting either before (lanes
1 to 3 and 5 to 7) or after (lanes 4 and 8) 1 h of incubation at 37°C with 167 U/ml of alkaline phosphatase (AP). Immunoblotting was performed with primary
antibodies against the proteins indicated at the right of the panels. eIF2-P, phosphorylated eIF2. (B and C) Monolayers of CEF or DF1 cells were left untreated
() or incubated () with 1,000 U/ml of chIFN for 24 h and then mock infected (M) or infected with the indicated viruses (ARV, 10 PFU/cell for 10 h; VV, 5
PFU/cell for 9 h; VSV, 5 PFU/cell for 6 h). The mock-infected cells of lanes 9 were incubated with 1 mM DTT for 75 min just before lysis. The cells of panels a were
incubated for the last 60 min with 100 Ci of [35S]methionine-cysteine before being lysed with RIPA buffer. The radioactive proteins of the extracts were resolved
by 10% SDS-PAGE and visualized by autoradiography. The positions of protein markers are indicated between the panels. The cells used for the experiments in
panels b to f were lysed at the same time as those of panel a, and the resulting extracts were subjected to Western blot analysis with antibodies against the proteins
indicated between the panels.
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molecular-weight compound is able to prevent PKR autophos-
phorylation by blocking the ATP-binding site of the kinase and
has been shown to be an efficient PKR inhibitor both in cultured
cells and in animal models (41, 42). First of all, we tested the ability
of this compound to prevent the activation of the PKR expressed
by IFN-primed DF1 cells. The results shown in Fig. 2A revealed
that the capacity of dsRNA to activate chPKR was inhibited by C16
in a dose-dependent manner and that maximal inhibition was
reached at a C16 concentration of 10 M. This, and our finding
that cell viability was not affected by the presence of 10 M C16 for
at least 12 h (data not shown), prompted us to use this inhibitor
concentration in subsequent studies with infected cells. Strikingly,
C16 induced a certain degree of eIF2 phosphorylation in IFN-
primed and -nonprimed uninfected cells (Fig. 2B, panel c, lanes 1
to 4) although this was not accompanied by significant protein
synthesis inhibition (Fig. 2B, panel a, lanes 1 to 4). Although we
do not understand why C16 promotes eIF2 phosphorylation
in uninfected cells and why this was not accompanied by pro-
tein synthesis inhibition, our finding that C16 induces eIF2
phosphorylation in cells that do not express detectable PKR
levels, like IFN-nonprimed uninfected DF1 cells (Fig. 2B, com-
pare lanes 1 and 2 in panels b and c), suggests that C16 promotes
eIF2 phosphorylation through the activation of an eIF2 kinase
other than PKR.
When added to IFN-nonprimed VV-infected DF1 cells, C16
did not significantly alter the level of eIF2 phosphorylation or the
rate of viral protein synthesis (Fig. 2B, compare lanes 5 and 6 in
panels a and c). However, C16 was able to prevent PKR activation,
to reduce the degree of eIF2 phosphorylation, and to rescue the
synthesis of viral proteins when it was added to IFN-treated VV-
infected cells (Fig. 2B, compare lanes 7 and 8 in panels a to c), thus
confirming our previous suggestion that PKR plays a key role in
the sensitivity of VV toward the antiviral action of IFN in avian
cells. In contrast, C16 did not promote the rescue of viral protein
synthesis in IFN-treated VSV-infected DF1 cells (Fig. 2B, compare
lanes 11 and 12 in panel a) although the inhibitor still promoted
the disappearance of the faint band corresponding to the slower-
migrating PKR isoform (Fig. 2B, compare lanes 11 and 12 in panel
b). These results suggest that IFN blocks the replication of VSV in
avian cells mainly through a PKR-independent mechanism, prob-
ably acting at a stage of the virus life cycle prior to viral protein
synthesis.
That VV is so sensitive to IFN in avian cells and that PKR plays
a key role in that resistance are striking results since the replication
of VV in most mammalian cells is quite resistant to IFN priming
(43), which has been attributed to the action of a plethora of anti-
IFN proteins expressed by the VV genome (44). Two of these
proteins, E3 and K3, which are encoded by the early viral genes
E3L and K3L, have been reported to counteract the antiviral action
of PKR (43, 45, 46). Removal of the genes encoding these two
anti-IFN proteins renders VV sensitive to IFN priming in many
cell lines (47, 48) although it has been suggested that E3 accounts
for most anti-PKR activity and that K3 has only a marginal effect
(34, 45). The E3 proteins p20 and p25 bind and sequester dsRNA
activator (49, 50) although direct interaction of E3 with PKR also
appears to be required for preventing PKR activation (51). Three
possibilities could account for the inability of E3 to prevent PKR
activation in IFN-primed VV-infected avian cells: (i) PKR might
block the synthesis of E3 if the kinase becomes active before early
viral genes are expressed; (ii) the intracellular levels of E3 might
FIG 2 Effect of PKR inhibitor C16 on PKR activation in DF1 cells. (A) DF1 cell
monolayers were primed with IFN for 24 h and then incubated for 5 h with the
indicated concentrations of C16. The cells were mock transfected ( or trans-
fected () with 10 g/ml of poly(I·C) and incubated for another 4 h. The cells
were then lysed, and the extracts were subjected to Western blot analysis using
anti-chPKR serum as the primary antibody. (B) Monolayers of DF1 cells were
left untreated (lanes 1, 2, 5, 6, 9, and 10) or incubated (lanes 3, 4, 7, 8, 11, and
12) with IFN for 24 h, and then the cells used for the experiments shown in the
even-numbered lanes were incubated with 10 M C16 for 30 min. The cells of
lanes 1 to 4 were mock infected (M), those of lanes 5 to 8 were infected with 5
PFU/cell of VV, and those of lanes 9 to 12 were infected with 5 PFU/cell of VSV.
At 8 hpi for VV-infected cells and at 5 hpi for VSV-infected cells, the cells used
for the experiment shown in panel a were incubated for 1 h with 100 Ci of
[35S]methionine-cysteine and lysed with RIPA buffer, and the radioactive pro-
teins of the extracts were resolved by 10% SDS-PAGE and visualized by auto-
radiography. The positions of protein markers are indicated on the right. At 9
hpi for VV-infected cells and at 6 hpi for VSV-infected cells, the cells of the
experiments shown in panels b to e were lysed, and the resulting extracts were
subjected to Western blot analysis with antibodies against the proteins indi-
cated on the right. (C) Monolayers of DF1 cells were left untreated (odd lanes)
or incubated (even lanes) with IFN for 24 h, and then the cells of lanes 1 and 2
were mock infected (M), whereas those of lanes 3 to 6 were infected with 5
PFU/cell of VV. At the indicated postinfection times the cells were lysed, and
the resulting extracts were subjected to Western blot analysis with antibodies
against PKR, actin, and E3 (p25 and p20), as indicated. (D) DF1 cells were
untreated (lanes 1, 3, 4, and 6) or treated with 10 M C16 (lanes 2 and 5) for 30
min. The cells were then mock infected (M; lanes 1 to 3) or infected with 5
PFU/cell of VV (lanes 4 to 6), and 1 h later the cells represented in lanes 3 and
6 were incubated with 40 g/ml of araC. From 8 to 9 hpi all cells were incu-
bated for 1 h with 100 Ci of [35S]methionine-cysteine; the cells were then
lysed with RIPA buffer, and the radioactive proteins were resolved by 10%
SDS-PAGE and visualized by autoradiography. The positions of protein mark-
ers are indicated on the left.
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not be sufficient to sequester all intracellular dsRNA generated in
these cells; and (iii) E3 might be unable to block PKR activation if
it fails to interact with the PKR of avian origin. To try to under-
stand why E3 is not able to prevent PKR activation in avian cells,
we performed a Western blot analysis to compare the intracellular
levels of E3 proteins in IFN-primed and -nonprimed DF1 cells.
The results shown in Fig. 2C revealed that IFN priming did not
inhibit the production of the E3 proteins p25 and p20 in VV-
infected DF1 cells at early or late times postinfection (p.i.), sug-
gesting that expression of early VV genes takes place normally in
IFN-primed avian cells, which in turn suggests that PKR activa-
tion takes place after the mRNAs of these genes have been trans-
lated. This suggestion is further supported by our finding that IFN
priming of avian cells does not inhibit the expression of an avian
reovirus gene controlled by an early VV promoter (see Fig. 5).
Curiously, although the incubation of VV-infected DF1 cells
with the PKR inhibitor C16 did not alter the rate of viral protein
synthesis, it induced a change in the expression pattern of the viral
polypeptides. Thus, the inhibitor promoted the expression of spe-
cific viral proteins and altered the rate of synthesis of several VV
polypeptides (Fig. 2B, compare lane 5 with lanes 6 and 8 in panel
a). One possibility is that C16 might block the expression of inter-
mediate and late VV genes, allowing the virus to express exclu-
sively its early genes. To test this hypothesis, we compared the
pattern of the viral proteins expressed in VV-infected DF1 cells
when these cells were incubated in the presence of either C16 or
cytosine arabinoside (araC). Cytosine arabinoside is a nucleoside
analog that has been shown to block the replication of the VV
genome in mammalian cells, thus preventing the expression of
intermediate and late viral genes (52). araC was similarly effective
on avian cells since the pattern of VV polypeptides expressed in
the presence of the inhibitor was quite different from the one
obtained in its absence (Fig. 2D, compare lanes 4 and 6) but sim-
ilar to the ones reported for the VV polypeptides synthesized in
mammalian cells in the presence of araC or at early infection times
(52). However, the pattern of the viral proteins synthesized in the
presence of araC was different from the one generated in the pres-
ence of C16 (Fig. 2D, compare lanes 5 and 6). These results suggest
that C16 induces deregulation of the temporal expression pattern
of the VV genome, allowing the virus to express early, intermedi-
ate, and late genes at the same time, although this suggestion re-
quires experimental confirmation.
Different responses of the three viruses to DTT-induced
eIF2 phosphorylation. One of the mechanisms used by the host
cell to inhibit viral replication and spread is the phosphorylation
of the alpha subunit of the translation initiation factor eIF2, and
therefore viruses use a variety of different countermeasures to
reduce the intracellular levels of phosphorylated eIF2. Thus,
some viruses inhibit the activation and/or the activity of eIF2
kinases, while others downregulate eIF2 phosphorylation or in-
duce dephosphorylation of the initiation factor subunit (53, 54).
Finally, some viruses express mRNAs that are able to initiate
translation at concentrations of phosphorylated eIF2 that pre-
clude the translation of most cellular mRNAs (55). To assess
whether the viruses employed in this study use strategies to deal
with eIF2 phosphorylation, we examined the capacity of virus-
infected avian cells to counteract the ability of DTT to induce
eIF2 phosphorylation. DTT was added to the medium of in-
fected cells at late infection times in order for the cells to have time
to express and accumulate viral proteins. The results revealed that
incubation with 1 mM DTT for 1 h was very effective in inducing
eIF2 phosphorylation and in blocking protein synthesis in unin-
fected avian cells (Fig. 3A and B, compare lanes 1 and 2 in panels a
and b). Similar results were obtained when VSV-infected cells
were incubated with DTT (Fig. 3A and B, compare lanes 5 and 6 in
panels a and b), suggesting both that VSV does not use counter-
FIG 3 Effect of DTT on protein synthesis and eIF2 phosphorylation in avian cells. Monolayers of CEF (A) and DF1 (B and C) cells were mock infected (M) or
infected with ARV (10 PFU/cell for CEF cells and 50 PFU/cell for DF1 cells) or with 5 PFU/cell of VSV or VV, as indicated. The cultured medium of the cells used
for the experiments shown in the even-numbered lanes was supplemented with 1 mM DTT 1 h before lysis. The cells of panels a were incubated for 45 min before
lysis with 100 Ci of [35S]methionine-cysteine; cells were then lysed with RIPA buffer (at 6 hpi for VSV-infected cells and at 9 hpi for the rest of the cells), and
radioactive proteins of the extracts were resolved by 10% SDS-PAGE and visualized by autoradiography. The positions of protein markers are indicated between
the panels. (C) The regions of the lanes selected for densitometric analysis of cellular (c) and viral (v) protein bands are indicated at both sides of panel a. The cells
of panels b to e were lysed at 9 hpi, and the resulting extracts were subjected to Western blot analysis with antibodies against the proteins indicated between panels
A and B or on the right of panel C. The samples shown on panel C were run on the same gel, but internal lanes were removed. For densitometric analysis of the
protein bands in panel a, the intensities of the whole lanes (Total) or of the selected lane regions indicated at both sides of the figure (c, cellular proteins; v, viral
proteins) were measured, and the percentages of intensities relative to lane 1 are indicated below lane 2, while the percentages of intensities relative to lane 3 are
shown below lane 4.
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measures to downregulate DTT-induced eIF2 phosphorylation
and that the translation of VSV mRNAs is very sensitive to eIF2
phosphorylation. In contrast, DTT did not provoke eIF2 phos-
phorylation or protein synthesis inhibition when added to VV-
infected avian cells (Fig. 3A and B, compare lanes 7 and 8 in panels
a and b), suggesting that VV expresses/induces factors that are able
to prevent eIF2 phosphorylation or to remove phosphate groups
from phosphorylated eIF2. Finally, treatment of ARV-infected
avian cells with DTT induced a slight increase in the level of eIF2
phosphorylation and caused inhibition of cellular protein synthe-
sis but not of viral protein synthesis (Fig. 3A and B, compare lanes
3 and 4). Furthermore, examination of lanes 3 and 4 in panels a of
Fig. 3A and B suggested that the inhibition of cellular protein
synthesis induced by DTT in ARV-infected cells is less pro-
nounced than that observed in uninfected cells. To confirm this
suggestion, we performed a densitometric analysis of the cellular
and viral protein bands obtained from uninfected and ARV-in-
fected DF1 cells when untreated or treated with DTT. The results
revealed that DTT inhibited the synthesis of cellular proteins in
uninfected cells by 80%, but the inhibition reached only 50% in
ARV-infected cells (Fig. 3C), probably because of reduced eIF2
phosphorylation. These results suggest both that ARV uses strat-
egies to downregulate eIF2 phosphorylation and that the trans-
lation of ARV mRNAs is less sensitive to eIF2 phosphorylation
than that of their cellular counterparts.
The capacity of dsRNA to activate PKR is diminished in
ARV-infected cells. The results shown so far suggest that ARV
uses strategies to prevent PKR activation and eIF2 phosphoryla-
tion, so we next examined whether the infection of avian cells with
ARV reduces the capacity of dsRNA to activate PKR. For this, CEF
and DF1 cells were primed with IFN, and 24 h later the cells were
either infected with ARV or left uninfected. At 6 h p.i. (hpi) the
cells were transfected with the synthetic dsRNA poly(I·C) and
lysed 4 h later, and the resulting cell extracts were subjected to
Western blot analysis. The results revealed that dsRNA transfec-
tion caused PKR activation in uninfected cells, as detected both by
the appearance of the lower-mobility PKR band and by increased
eIF2 phosphorylation (Fig. 4A and B, compare lanes 1 and 2).
PKR activation was more evident in DF1 cells, where the PKR
band corresponding to nonphosphorylated PKR was drastically
reduced and replaced by a lower-mobility PKR isoform (Fig. 4B,
panel b, lane 2). Our results further revealed that the capacity of
transfected poly(I·C) to promote PKR activation was downregu-
lated in ARV-infected avian cells, as detected by reduced phos-
phorylation of both PKR and eIF2 (Fig. 4A and B, compare lanes
3 and 4 in panels b and c). These results suggest that ARV expresses
or induces factors that are able to prevent PKR activation.
The ARV protein sigmaA is able to prevent PKR activation. It
has been previously shown that the ARV protein sigmaA binds
dsRNA very tightly in an irreversible and sequence-independent
manner (27, 56, 57), and two reports have provided evidence that
sigmaA antagonizes the interferon-induced cellular response
against ARV by preventing PKR activation (24, 26). However, the
anti-PKR activity of sigmaA was based on indirect evidence since
at that time we were unable to directly monitor chPKR activation
and eIF2 phosphorylation in avian cells. Once these conditions
were established, we reexamined the anti-PKR effect of sigmaA.
We performed the experiments in DF1 cells because the phos-
phorylated and nonphosphorylated PKR isoforms expressed by
these cells are better resolved electrophoretically than the ones
expressed by CEF cells. In a first attempt to determine the anti-
PKR activity of sigmaA, we used two recombinant VVs, one that
contains the sigmaA-encoding gene (VV-S2) (26) and one that
contains the luciferase gene (VV-Luc) (28), with both genes con-
trolled by early viral promoters. IFN-primed DF1 cells were in-
fected with these viruses, and one set of cells was labeled for 1 h at
8 hpi with [35S]methionine-cysteine for protein synthesis analysis,
whereas the other set was lysed at 9 hpi for Western blot analysis.
As expected, IFN priming of uninfected cells induced PKR expres-
sion, but the protein was expressed as an inactive kinase because
we could not detect either a shift of PKR isoforms, eIF2 phos-
phorylation, or protein synthesis inhibition (Fig. 5A, compare
lanes 1 and 2 in panels a, c, and d). On the other hand, IFN prim-
ing of VV-Luc-infected cells induced not only PKR expression but
also a PKR shift toward the phosphorylated slower-mobility iso-
form (Fig. 5A, compare lanes 3 and 4 in panel c), and this was
accompanied by both increased eIF2 phosphorylation and the
inhibition of viral protein synthesis (Fig. 5A, compare lanes 3 and
4 in panels a and d). In contrast, IFN priming of the cells infected
with the sigmaA-expressing virus VV-S2 did not promote a PKR
shift, eIF2 phosphorylation, or the inhibition of viral protein
synthesis (Fig. 5A, compare lanes 5 and 6 in panels a, c, and d),
indicating that sigmaA expression protects VV against the antivi-
ral action of IFN by blocking PKR activation, which in turn sup-
ports our previous suggestion that PKR plays a key role in the
sensitivity of VV toward IFN in avian cells. Furthermore, the ca-
pacity of IFN to inhibit viral protein synthesis in cells infected with
VV-Luc, but not in the ones infected with VV-S2, was dose depen-
dent (Fig. 5B). However, the two recombinant VVs were similarly
resistant to DTT treatment (Fig. 5C), which again suggests that VV
expresses factors that are able to prevent eIF2 phosphorylation.
The crystal structure of a bacterially expressed recombinant
sigmaA has been solved, and two key arginine residues (Arg-155
and Arg-273) involved in dsRNA binding have been identified
because mutation of either of these two residues abolishes dsRNA
binding (27). To determine whether there is a correlation between
FIG 4 Effect of ARV infection on the capacity of dsRNA to activate PKR.
Monolayers of IFN-primed CEF (A) and DF1 (B) cells were mock infected (M)
or infected with ARV (10 PFU/cell for CEF cells and 20 PFU/cell for DF1 cells),
as indicated. At 6 hpi the cells were mock transfected () or transfected ()
with 10 g/ml of poly(I·C), as indicated. The cells were lysed 4 h later, and the
resulting extracts were subjected to Western blotting with antibodies against
the proteins indicated in the middle of the figure.
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the dsRNA binding and the anti-PKR activities of sigmaA, we
compared the capacities of wild-type sigmaA and its mutant
R155A (in which Arg-155 has been replaced by alanine) to prevent
dsRNA-induced PKR activation. To accomplish this, DF1 cells
were transfected with the empty pcDNA plasmid or with recom-
binant plasmids expressing sigmaA or its R155A mutant, and 3 h
later the cells were treated with IFN for 18 h and finally transfected
with poly(I·C) for another 4 h. One set of the cells was then pro-
cessed for immunofluorescence analysis, and the other set was
lysed for Western blot analysis. The immunofluorescence pictures
shown in Fig. 6A revealed that the sigmaA protein (lane 2), but not
the R155A mutant (lane 3), colocalized with transfected dsRNA in
the cell cytoplasm, thus confirming that sigmaA, but not the
R155A mutant, binds dsRNA. The Western blot analysis shown in
Fig. 6B revealed that transfection of dsRNA into cells containing
either the empty plasmid or the R155A-expressing plasmid pro-
moted a PKR shift toward the lower-mobility hyperphosphory-
lated band (compare lanes 1 and 2 and lanes 5 and 6). In contrast,
this shift hardly took place in the cells transfected with the
sigmaA-expressing plasmid (compare lanes 3 and 4). These results
not only confirm that sigmaA is able to prevent the activation of
PKR induced by dsRNA but also indicate that this property relies
on the capacity of sigmaA to bind and sequester activator dsRNA.
DISCUSSION
Previously published studies have revealed that the replication of
ARV in cultured chicken cells is much more resistant to the anti-
viral action of chIFN than the replication of VV and VSV (23, 24,
26). In this study, we have tried to elucidate the molecular mech-
anisms that control the susceptibility of these three viruses toward
chIFN in avian cells by examining protein synthesis, PKR activa-
tion, and eIF2 phosphorylation. Our results reveal that each of
these viruses elicits different responses to IFN priming.
Previous studies from different laboratories reported conflict-
ing results regarding the stage of the VV life cycle blocked by IFN
in avian cells. Thus, the results of Bialy and Colby (58) suggested
that chIFN inhibits the synthesis of VV transcripts in CEF cells,
whereas the results of Esteban and Metz (59) indicated that the
FIG 5 Sensitivity of recombinant vaccinia viruses VV-Luc and VV-S2 toward IFN and DTT. (A) Monolayers of DF1 cells that had been IFN primed () or left
unprimed () were mock infected (M) or infected with 5 PFU/cell of the indicated recombinant vaccinia viruses. At 8 hpi the cells used in the experiment shown
in panel a were incubated for 1 h with 100 Ci of [35S]methionine-cysteine and lysed with RIPA buffer, and the radioactive proteins of the extracts were resolved
by 10% SDS-PAGE and visualized by autoradiography. At 9 hpi the cells used in the experiments shown in panels b to f were lysed, and the resulting extracts were
subjected to Western blot analysis with antibodies against the proteins indicated at the right. The samples used for the experiment shown in panel a were run on
the same gel, but an internal lane between lanes 2 and 3 was removed. (B) Monolayers of DF1 cells primed with the IFN concentrations shown at the top of the
figure were mock infected (M) or infected with the indicated recombinant vaccinia viruses indicated. At 8 hpi the cells were radiolabeled and processed as
described for panel A(a). (C) Monolayers of DF1 cells were mock infected (M) or infected with the indicated recombinant vaccinia viruses. At 8 hpi the cells were
incubated for 1 h with 1 mM DTT, and then one set of cells was processed for Western blotting with the antibodies indicated at the right of panels b to e. The other
set was incubated for the last 45 min with 100 Ci/ml of [35S]methionine-cysteine, and then processed as described for panel A(a). The position of sigmaA is
indicated at the right of the panels.
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cytokine induces viral protein synthesis inhibition while stimulat-
ing the synthesis of early VV transcripts. On the other hand, the
study by Grün et al. (60) suggested that priming CEF cells with
IFN caused inhibition of VV protein synthesis by promoting the
degradation of early viral transcripts, while the data of Degen et al.
(61) revealed that the degradation of VV mRNAs cannot be solely
responsible for the inhibition of protein synthesis observed in
IFN-treated VV-infected CEF cells. The results presented in the
current study indicate that priming of avian cells with a recombi-
nant chIFN- induces viral protein synthesis inhibition and that
PKR plays a key role in that inhibition. This conclusion is based on
our findings that priming of VV-infected avian cells with IFN
provokes PKR activation, eIF2 phosphorylation, and the inhibi-
tion of viral and cellular protein synthesis. Furthermore, our find-
ing that IFN priming does not reduce the intracellular levels of two
proteins expressed by early VV genes, like VV E3 and ARV sigmaA
(Fig. 2C and 5A, respectively), suggests that PKR activation does
not take place until after the parental virus expresses the genes
controlled by early promoters. Thus, it seems that the dsRNA
required to activate PKR is generated in IFN-primed avian cells
during the expression of the intermediate/late genes and that PKR
activation at this stage precludes intracellular viral amplification
by blocking ribosomal translation. This situation is reversed when
IFN-primed VV-infected cells are cultured in the presence of the
specific PKR inhibitor C16 or when VV expresses the ARV anti-
PKR protein sigmaA.
The results of this study also reveal that the IFN sensitivity of
wild-type VV in avian cells is similar to that reported for VV mu-
tants lacking the E3L gene in mammalian cells (48, 50). Thus, the
E3L-lacking VV mutants are very sensitive to IFN priming but
become IFN resistant when they express specific dsRNA-binding
proteins from other viruses, like the mammalian reovirus protein
sigma3 or the influenza virus NS1 protein (62, 63). Similarly, we
have found that VV replication in avian cells changes from IFN
sensitive to IFN resistant when VV expresses the ARV dsRNA-
binding protein sigmaA. Thus, it appears that E3 is either non-
functional in avian cells or that its concentration within IFN-
primed VV-infected CEF cells is not high enough for sequestering
all the dsRNA generated in these cells during virus transcription.
Our previous finding that RNase L is not active in IFN-treated
VV-infected CEF cells (26) suggests that OAS remains inactive
because of the dsRNA-binding activity of E3, despite the fact that
chicken IFN induces very high intracellular levels of OAS in CEF
cells (24, 64). This, in turn, suggests that E3 is functional in avian
cells and that the lack of anti-PKR activity that we found in IFN-
primed VV-infected avian cells could be due to the inability of E3
to heterodimerize with chPKR although this suggestion requires
experimental confirmation.
In contrast to IFN priming, eIF2 is not phosphorylated, and
viral protein synthesis is not inhibited when VV-infected avian
cells are treated with DTT even though DTT efficiently induces
eIF2 phosphorylation and protein synthesis inhibition in both
uninfected and VSV-infected avian cells. These results suggest that
VV-infected avian cells contain factors that prevent PERK-in-
duced eIF2 phosphorylation. The most likely candidate is the
VV-encoded K3 protein. This protein, which is encoded by a viral
early gene, has homology to the amino-terminal region of eIF2
and acts as a nonphosphorylatable PKR pseudosubstrate to com-
petitively inhibit eIF2 phosphorylation (65, 66). Although we do
not have specific antibodies to analyze the intracellular K3 con-
centration, we assume that, as with E3 and sigmaA, IFN priming
does not inhibit the synthesis of K3. Then, if this protein is able to
prevent PERK-induced eIF2 phosphorylation in avian cells, why
is K3 able to block eIF2 phosphorylation in DTT-treated cells but
not in IFN-treated cells? One possibility is that K3 might act as a
pseudosubstrate for chicken PERK but not for chicken PKR since
it has been shown that rapid evolution of PKR in different species
alters its sensitivity to K3 while maintaining its eIF2 phosphor-
ylation activity (67). Another possibility is that intracellular viral
amplification would be required for K3 to reach the threshold
concentration necessary for preventing eIF2 phosphorylation.
That goal could not be achieved in IFN-primed cells because viral
amplification would be blocked by PKR activation, whereas high
levels of early viral proteins like K3 would accumulate in DTT-
treated cells because the inhibitor was added to the medium at late
infection times.
In the case of VSV we observed that IFN priming of avian cells
induced the following: (i) the activation of a small PKR fraction,
(ii) a slight increase in eIF2 phosphorylation, (iii) the arrest of
viral protein synthesis, and (iv) a partial rescue of cellular protein
FIG 6 Effect of sigmaA dsRNA-binding activity on its anti-PKR function. (A) Monolayers of DF1 cells were transfected for 3 h with an empty pcDNA plasmid
() or with recombinant pcDNA plasmids containing inserts encoding wild-type sigmaA (S2) or the sigmaA R155A mutant (S2-R155A). The cells were then
primed with IFN for 18 h and subsequently transfected with 10 g/ml of poly(I·C) for another 4 h. Finally, the cells were fixed with formaldehyde and
immunostained with green for sigmaA and red for dsRNA and with DAPI (blue). Stained cells were visualized by fluorescence microscopy. (B) Monolayers of
DF1 cells were transfected for 3 h with the same plasmids used for the experiment shown in panel A and then incubated in the presence of 1,000 U/ml of IFN for
18 h. One set of cells was then mock transfected () while the other set was transfected () with 10 g/ml of poly(I·C). The cells were incubated for another 4
h and then lysed, and the resulting extracts were subjected to Western blot analysis with antibodies against the proteins indicated at the right. S2, VV-S2 expressing
sigma A; S2-R155A, VV-S2 expressing sigmaA R155A.
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synthesis. Furthermore, we found that the PKR inhibitor C16 was
unable to rescue the synthesis of VSV proteins in IFN-primed
cells. Taken together, these data suggest that chIFN induces a
blockade of VSV replication at a step prior to viral protein synthe-
sis. Accordingly, IFN has been reported to inhibit the replication
of VSV in mammalian cells at stages of the virus life cycle like
penetration, decapsidation, and/or viral transcription (68–73).
On the other hand, our findings that eIF2 is phosphorylated
and that VSV protein synthesis is arrested in DTT-treated cells
indicate both that VSV does not express factors for preventing
PERK-mediated eIF2 phosphorylation and that translation of
VSV mRNAs is very sensitive to phosphorylation of this initiation
factor, as has been previously documented (34). Taken together,
these results suggest that ISGs other that PKR are involved in
the IFN-induced arrest of VSV replication in avian cells, a sit-
uation already reported for the replication of this virus in
mammalian cells (73–76).
In contrast to replication of VV and VSV, the replication of
ARV in avian cells is quite resistant to IFN priming even though
efficient expression of both type I interferons and PKR takes place
in ARV-infected avian cells (77). Thus, it appears that ARV trig-
gers anti-IFN strategies for efficient replication in IFN-primed
avian cells, and the results of this study suggest that one strategy is
the prevention of PKR activation since we have found that PKR
does not become active upon IFN priming of ARV-infected avian
cells. This suggests that ARV expresses/induces factors that pre-
vent PKR activation, and one likely candidate is the ARV core
protein sigmaA, a protein that binds tightly to dsRNA in an irre-
versible manner (27, 56, 57). Previous studies have provided the
following indirect evidence that sigmaA inhibits PKR activation:
(i) the capacity of extracts of ARV-infected cells to overcome the
translational inhibitory activity of dsRNA in reticulocyte lysates is
lost upon removal of protein sigmaA; (ii) a recombinant protein
sigmaA fused to maltose-binding protein is able to relieve the
translation-inhibitory activity of dsRNA in reticulocyte lysates by
blocking the activation of endogenous dsRNA-dependent en-
zymes; (iii) transient expression of sigmaA in HeLa cells rescues
gene expression of a vaccinia virus mutant lacking the E3L gene;
(iv) insertion of the sigmaA-encoding gene into vaccinia virus
confers protection for the virus against interferon in chicken cells;
and (v) expression of recombinant sigmaA in mammalian cells
interferes with PKR function (24, 26). In the present work we
provide direct evidence that ARV infection and sigmaA expres-
sion are both able to downregulate PKR activation and eIF2
phosphorylation. We further show that the capacity of sigmaA to
prevent PKR activation is linked to its dsRNA-binding activity
since a sigmaA mutant lacking this activity displayed a reduced
ability to prevent PKR activation (Fig. 6B). Thus, sigmaA should
be included in the list of viral proteins that not only display
structural functions but also have anti-IFN properties, like the
nucleoprotein of arenaviruses (78), the glycoprotein of hanta-
viruses (79), and the matrix proteins of both VSV and Thogoto
virus (80, 81).
It has been reported that the E3L protein of VV prevents PKR
activation not only by sequestering dsRNA activator but also by
binding to PKR and forming a ternary complex with PKR and
dsRNA (51). This prompted us to assess whether the ARV pro-
tein sigmaA similarly interacts with chPKR, but such interac-
tion could not be detected when two-hybrid pulldown assays or
colocalization experiments were performed (data not shown),
suggesting that the anti-PKR activity of sigmaA relies exclusively
on its dsRNA-binding activity. This would explain why both PKR
and RNase L remain inactive in IFN-primed ARV-infected avian
cells (26).
Our results also demonstrate that DTT treatment of ARV-in-
fected avian cells induces moderate phosphorylation of eIF2 and
that this causes a drastic inhibition of cellular protein synthesis,
whereas viral protein synthesis is hardly affected. Furthermore,
DTT-induced eIF2 phosphorylation and cellular protein synthe-
sis inhibition are more pronounced in uninfected cells than in
ARV-infected cells, suggesting that the inhibition of cellular pro-
tein synthesis is a direct response to eIF2 phosphorylation. These
results further indicate that the translation of ARV mRNAs is
more resistant to eIF2 phosphorylation than the translation of
their cellular counterparts.
Some cellular and viral transcripts have been reported to be
quite resistant to eIF2 phosphorylation (15, 55, 82). One class of
these mRNAs, such as those encoding activating transcription fac-
tor 4 (ATF4), contain upstream open reading frames (uORFs) in
their 5= untranslated regions and require these uORFs and eIF2
phosphorylation for efficient translation of the main ORF (15,
82–84). Another class of transcripts contain internal ribosome
entry site (IRES) or downstream loop (DLP) structures, which
allow them to recruit Met-tRNAi
met in the absence of eIF2 (40, 82,
85–95). On the other hand, phosphorylation of eIF2 has been
reported to occur in cells infected with rotavirus, a member of the
Reoviridae family; under these restrictive conditions, the synthesis
of most cellular proteins is inhibited while viral transcripts are
efficiently translated (96), suggesting that translation of rotavirus
transcripts is quite resistant to eIF2 phosphorylation. Finally,
some IRES-containing cellular and viral transcripts have been re-
ported to use alternative initiator factors, such as 2A, 5B, 2D, and
MCT1/DENR, to replace the function of eIF2 for initiator tRNA
delivery (55, 82). Since most ARV transcripts are monocistronic
and do not contain uORFs in their short 5= untranslated regions
(97), it will be interesting to assess whether ARV mRNAs utilize an
eIF2-independent mode of translation and, if so, whether they use
alternative noncanonical factors for initiator tRNA recruitment.
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